About Us

Welcome to BioConnect

OUR MISSION

Enabling Trust in the Connected World

Since 2010, BioConnect has been providing biometric access control solutions to verify a person’s identity and protect your most valuable assets.

BioConnect was the first to bring to market a biometric mobile authenticator for physical access. Allowing the enterprise to secure their physical doors and spaces with the use of biometric identity verification right from a mobile device.

When BioConnect introduced the Trust Platform, it enabled the enterprise to finally connect all of their existing access control systems, biometric readers, mobile authenticators and small-space access control into one unified system that spans the entire organization.

In 2021, BioConnect purchased MedixSafe, a long time BioConnect partner and supplier of solutions for secure access to Narcotics Safes, Cabinets and Lockers. Together BioConnect and MedixSafe are uniquely positioned to offer solutions to the toughest security problems that an organization faces, providing security at scale that establishes a strong level of trust by unifying a person’s identity across physical, IoT and digital applications.

We’ve grown alongside the industry

2010

Company Founded

Toronto, Canada

2013

Physical Access

BioConnect platform integrates into 80% of the access control market

2016

Digital Access

Replacing tokens & other secrets with mobile authentication for enterprise applications

2019

Unified Digital & Physical Access

Frictionless and passive authentication for physical and digital access

2022

Sovereign Identity Utility

A continuous trust score for identity assurance across all platforms and applications

OUR CUSTOMERS

Security, at scale.

Unparalleled security. Enterprise scale.

BioConnect has been securing North America’s most-critical infrastructure and complex enterprise environments for over a decade, with industry-leading biometric access control.

Over 1,000 enterprises have chosen BioConnect’s platform to provide reliable, unified, secure access that grows at the speed of their business.

BioConnect Selected into the MaRS Momentum Scaling Program

Selected as one of a few tech companies capable to scale past $100 million by 2024.

The program is funded by the Federal Economic Development Agency, with the goal of assisting executives turn high-potential companies into high-growth global powerhouses.

Read the Full Report Here

Meet the Team

The Founder

Rob Douglas

BioConnect Founder, Chairman, & CEO

Rob Douglas is the Chairman and CEO of BioConnect. Over the last fourteen years, he has been providing global market leadership in the biometric identity market.

With his strong business acumen, Rob sees the impact to fraud and operational friction to corporations, financial institutions, healthcare, education and government organizations that would save billions in costs if they simply interacted with people.